Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bye Bye, AMD! Cathie Wood Ditches 57K Advanced Micro Shares

Cathie Wood offloads AMD along with a bunch of other tech stocks as she moves away from semiconductor.

NVDA : 173.48 (-1.29%)
META : 568.26 (-1.89%)
ROKU : 93.74 (-1.22%)
CRCL : 85.89 (-5.34%)
AMD : 206.09 (-1.96%)
$IUXX : 23,529.65 (-2.04%)
TEM : 45.49 (-3.27%)
TSM : 334.41 (-2.07%)
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR-based notification system designed to address the undertreatment of significant valvular heart disease...

TEM : 45.49 (-3.27%)
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global nonprofit...

TEM : 45.49 (-3.27%)
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the publication of a new study in JCO Precision Oncology...

TEM : 45.49 (-3.27%)
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada, today announced an expanded,...

TEM : 45.49 (-3.27%)
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Morgan Stanley Technology, Media, and Telecom...

TEM : 45.49 (-3.27%)
Tempus: Q4 Earnings Snapshot

Tempus: Q4 Earnings Snapshot

TEM : 45.49 (-3.27%)
Tempus Reports Fourth Quarter and Full Year 2025 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter and year ended December 31,...

TEM : 45.49 (-3.27%)
2 Tech Bets Cathie Wood is Quietly Trimming Right Now: Should You Too?

Wood reduced her stake in these two tech bets but did not completely exit. What does that imply?

TER : 304.13 (-2.58%)
ARKW : 118.00 (-2.70%)
ARKQ : 112.64 (-1.63%)
PINS : 18.12 (-0.93%)
TEM : 45.49 (-3.27%)
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of its new HRD-RNA algorithm. This next-generation model represents...

TEM : 45.49 (-3.27%)

Barchart Exclusives

The Iran War Thrust Aluminum Prices Into the Spotlight, but Is There a Long-Term Bull Case for Rio Tinto Stock?
With aluminum markets tightening and prices rising, Rio Tinto stock is riding the surge. But is this the start of a lasting upcycle, or just a short-term spike driven by geopolitical noise? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.